Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Francesco Burzotta , Carlo Trani Added: 3 years ago
Diseased coronary bifurcations are frequently treated by percutaneous coronary interventions (PCI), and in these complex lesions the adoption of the most suitable treatment technique and the selection of the most appropriate coronary stent are of primary importance. Clinical evidence suggests that drug-eluting stent (DES) implantation using a provisional approach is the gold standard for… View more
Author(s): Carlotta Sorini Dini , Giulia Nardi , Francesca Ristalli , et al Added: 3 years ago
In the 18th century, Edward Jenner and Caleb Hillier Parry, two British physicians, independently noticed that coronary ossification was often present in patients dying of ‘syncope anginosa’.1 Coronary angiography opened the possibility of expanding these observations to living patients and offered revascularisation options. During surgery, it was often possible to modify the position of the… View more
Author(s): Peter Mortier , Heleen MM van Beusekom , Matthieu De Beule , et al Added: 3 years ago
Incomplete stent apposition (ISA) or stent malapposition is the lack of contact between stent struts and the underlying arterial wall. ISA has been associated with significantly higher levels of thrombus deposition1 and is typically assessed by intravascular imaging techniques such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS).2–4 These imaging modalities are useful to… View more
Author(s): Demosthenes G Katritsis , Ioannis Pantos Added: 3 years ago
The functional severity of atherosclerotic coronary lesions is the single most important prognostic factor in patients with documented coronary artery disease (CAD). Assessment of the haemodynamic significance of coronary artery lesions by invasive fractional flow reserve (FFR) measurement now has an I-A indication by the European Society of Cardiology (ESC) to identify haemodynamically relevant… View more
Author(s): Dominic J Allocco , Mary V Jacoski , Barbara Huibregtse , et al Added: 3 years ago
Advances in drug-eluting stent technology have continued to improve clinical outcomes for patients undergoing percutaneous coronary intervention (PCI). The development of the platinum– chromium (PtCr) alloy and Element™ stent architecture (or platform) is the result of more than eight years of research and development by Boston Scientific Corporation (BSC; Natick, MA, US) and builds on a pedigree… View more
Author(s): Alexander Ruebben , Juergen Boeing , Norbert Weiss Added: 3 years ago
More drug-eluting balloons are entering the market. However, it is difficult for the user to understand the differences between these devices. This article aims to increase understanding of these devices, from the point of view of the manufacturer and for benefit of the user. The differences of the balloon coating can be found: in the loading dose; in the excipient; and in the way the… View more
Author(s): Alexander Ruebben , Juergen Boeing , Norbert Weiss Added: 3 years ago
The Elutax© is a rapid exchange percutaneous transluminal coronary angioplasty (PTCA) catheter. There are two versions: one for standard-size coronary and small peripheral vessels (Elutax 2nd Generation) and one for small coronary vessels (Elutax SV). The Aachen Resonance® Elutax drug-eluting balloon family was developed especially for coronary arteries and venous bypass as well as for small… View more
Author(s): Hector M Garcia-Garcia Added: 6 years ago
Hector Garcia-Garcia discusses comparison of clinical outcomes between Magmaris and Orsiro in a pooled patient level analysis from BIOSOLVE-II AND III AND BIOFLOW-II. Filmed by Radcliffe Cardiology on-site at ACC 2018. This interview was supported by Biotronik View more